By Art Gross – We have had quite a year so far in 2020, and if you are in healthcare, you were hit especially hard with something that you likely didn’t adequately prepare to deal with. However, according to a recent report from Black Book Market Research LLC, the healthcare industry has no idea what could hit them in 2021. But with this particular threat, you can prepare.
Read More
By Rob Anthony – As the compliance dates for the 21st Century Cures Act: Information Blocking, Interoperability, and the ONC Health IT Certification Program Final Rule (ONC Cures Act Final Rule) draw nearer, ONC has created additional resources to assist the health IT developer community.
By Matt Fisher – After a bit longer of a delay than was initially expected, the Department of Health and Human Services released a proposed rule to change pieces of HIPAA. The proposed rule is the outcome from a request for information that closed in February of 2019, where HHS posed a number of questions mostly focused on how HIPAA interacts with value based care goals.
The thought leaders in our community are good about sharing their thoughts on the issues of today. Here are the top read and shared guest posts of 2020 that we think deserve sharing again.
New On Demand Dr. Nick: The Incrementalist: With guest Ramin Bastani, CEO of Healthvana, who has built a direct communication platform for patients and doctors that has been working to deliver test results quickly and accurately for HIV for a number of years and has expanded into COVID19.
By Lyndsey Lord RN MBA – For both safety and efficiency, providers must be creative in caring for a growing patient population. After reading CMS’ recent announcement of the Acute Hospital Care at Home program, it is clear that clinical care will continue to expand beyond the four-walls of the hospital.
New On Demand Dr. Nick: The Incrementalist: With guest Dr. Zoë McLaren, Ph.D., Associate Professor in the School of Public Policy at the University of Maryland, Baltimore County. Zoë has a broad and deep set of experiences when it comes to effectively gathering data to combat infectious disease…
By Drew Ivan – In December 2020, the FDA approved the Pfizer/BioNTech vaccine for emergency use in the U.S., making it the fastest vaccine to be brought to market. Approval of the vaccine has come just 10 months after the first COVID-19 cases were reported in the U.S. A second vaccine, from Moderna, also recently gained FDA approval.
By Matt Fisher – Every year brings its own successes and trials, but 2020 brought more than its fair share of trials. The biggest issue that dominated healthcare throughout the year (and will continue to do so into 2021) was COVID-19.